Search by Drug Name or NDC

NDC 50458-0554-10 INVEGA 1.5 mg/1 Details

INVEGA 1.5 mg/1

INVEGA is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is PALIPERIDONE.

MedlinePlus Drug Summary

Paliperidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Paliperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 50458-0554-10
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Paliperidone

Product Information

NDC	50458-0554
Product ID	50458-554_039a5dde-bc31-0348-e063-6294a90ad5b3
Associated GPIs	59070050007505
GCN Sequence Number	065667
GCN Sequence Number Description	paliperidone TAB ER 24 1.5 MG ORAL
HIC3	H7T
HIC3 Description	ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
GCN	27685
HICL Sequence Number	034343
HICL Sequence Number Description	PALIPERIDONE
Brand/Generic	Brand
Proprietary Name	INVEGA
Proprietary Name Suffix	n/a
Non-Proprietary Name	paliperidone
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	1.5
Active Ingredient Units	mg/1
Substance Name	PALIPERIDONE
Labeler Name	Janssen Pharmaceuticals, Inc.
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021999
Listing Certified Through	2024-12-31

Package

NDC 50458-0554-10 (50458055410)

Pricing Information	N/A
NDC Package Code	50458-554-10
Billing NDC	50458055410
Package	10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-554-10) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date	2009-09-10
NDC Exclude Flag	N